Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Todd Franklin Watanabe currently holds 846,263 shares of Arcutis Biotherapeutics, Inc. (ARQT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Todd Franklin Watanabe has been a net seller of ARQT stock. They have purchased $9.3K and sold $2.7M worth of shares.
Todd Franklin Watanabe's most recent insider trade was on Aug 2, 2024, when they sold 14,487 shares at $9.02 per share.
Todd Franklin Watanabe serves as Executive at Arcutis Biotherapeutics, Inc. (ARQT). They have executed 98 insider transactions totaling $2.7M over their tenure at the company.
Todd Franklin Watanabe holds the position of Executive at Arcutis Biotherapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Todd Franklin Watanabe has shown a selling trading pattern, with $9.3K in total purchases and $2.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Todd Franklin Watanabe was on Jul 8, 2022, when they sold $180.1K worth of ARQT shares. This transaction involved 7,087 shares at $25.41 per share.
Todd Franklin Watanabe currently owns 846,263 shares of Arcutis Biotherapeutics, Inc. (ARQT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Todd Franklin Watanabe's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Todd Franklin Watanabe has 98 Form 4 filings on record as an insider at Arcutis Biotherapeutics, Inc..
Set alerts for Todd Franklin Watanabe and 40,000+ other insiders.